ULTRAGENYX PHARMACEUTICAL IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ULTRAGENYX PHARMACEUTICAL IN CALL, CUSIP 90400D908.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ULTRAGENYX PHARMACEUTICAL IN CALL, CUSIP 90400D908.